Antimicrobial Agents and Chemotherapy · 2003 · 26 citations · 15 references
Life SciencesInfectious DiseasesMicrobiologyDiagnostic MicrobiologyMedical MicrobiologyMicrobial GeneticsAntibacterial PharmacologyAntibiotic ResistanceAntibiotic Resistance MechanismsEnzyme InhibitionAntibiotic Therapy For ChlamydiaChlamydia SusceptibilityFluoroquinolone AntibioticsQuinolone Resistance Genes
The gyrA and gyrB genes of Chlamydia pneumoniae TW-183 were cloned, and their proteins were purified by use of a fusion system with a maltose-binding protein. The 50% inhibitory concentrations of garenoxacin, sparfloxacin, moxifloxacin, gatifloxacin, and levofloxacin were 10.1, 47.5, 39.6, 64.2, and 156.9 microg/ml, respectively, and the MICs against C. pneumoniae TW-183 were 0.008, 0.016, 0.063, 0.125, and 0.25 microg/ml, respectively.
15
In vitro Activity of BAY 12-8039, a New 8-Methoxyquinolone
A. Dalhoff, Uwe Petersen, Rainer Endermann · Chemotherapy · 2009 · 175 citations
Antibacterial Spectrum of a Novel Des-Fluoro(6) Quinolone, BMS-284756
J Fung-Tomc, Beatrice Minassian, B Kolek et al. · Antimicrobial Agents and Chemotherapy · 2000 · 166 citations